When Strong Science Still Struggles
The hidden meaning problem in emerging markets
The room was full of people who knew what they were looking at. The mechanism was airtight. The team was brilliant. And the air still shifted — not hostile (okay, maybe a little hostile), not dismissive, just unanchored. Investors nodding but not leaning in. Customers curious but not committing. Teams subtly explaining the same product three, four, five different ways.
That moment used to frustrate the heck out of me. Now I recognize it almost instantly. I’ve been in marketing and communication work for more than 35 years and spent most of that time in markets that didn’t quite exist yet. Interactive entertainment before gaming systems. Early digital before the dot bomb. Enterprise technology before it was called SaaS. Wearable neurotechnology before most people knew where to place it. Women’s health before it was cool.
Different industries, different constraints, different acronyms — and remarkably, the same pattern underneath.
The challenge of building without category language
When you’re building something the market doesn’t yet have language for, traditional marketing doesn’t just underperform, it misfires.
The product can be excellent and the science can be clean, and there's still no shared schema. No mental shelf where the thing neatly fits.
In an emerging or pre-category market, customers don't know how to categorize you, and investors don't know what to benchmark against. Teams strain at explaining the same product five different ways. The friction shows up everywhere — longer sales cycles, repeated deck rewrites, a traction line that feels heavier than it should for the substance underneath.
Over time, I stopped chasing channels and started studying belief — what people have to understand before they can act, and what story has to make sense before adoption stops being a fight.
Before you blame the marketing
Look into the meaning.
Why frontier health changes the stakes
That shift is what pulled me toward frontier health. When you're building something that touches the body, the nervous system, a diagnosis, or a long-term outcome, clarity is doing ethical work. Narrative coherence shapes trust. Trust shapes adoption. And in this field, adoption is the difference between a clinical breakthrough and a clinical breakthrough nobody understands or can access.
When mechanism, meaning, and market line up
When the three line up, momentum changes shape.
Clinicians who were polite-but-noncommittal start asking how to refer. The "can you simplify this" request fades from investor calls. Early adopters commit without needing the long version of the brief.
The part I care about most lives further downstream — patients getting access sooner, better outcomes, quality-of-life shifts that never show up in any marketing dashboard. Meaning has to land first for any of that to follow.
The work before the work
Before the next campaign, the next hire, or the next vendor brief — find out whether your commercial foundation is ready to carry it. The Meaning-Market Fit™ Self-Check is free and takes 5 minutes.